HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ebola Crisis Causes Drug Claim Symptoms In Products Marketed As Supplements

This article was originally published in The Pink Sheet Daily

Executive Summary

FTC joins FDA in one of the three warning letters to firms claiming their products can either prevent or treat Ebola.

You may also be interested in...

Like Other Outbreaks, Coronavirus Symptoms Include False Health Claims, Price-Gouging

FDA isn't alone monitoring drug, medical device and food companies making false Covid-19 treatment claims. New York AG warns Jim Bakker, UK agency cuts off face mask ads, Amazon removes thousands of products priced to cheat fearful consumers and Facebook cuts false ads.

HBW US Executive Decisions: Engle Leaves FTC, Changes At Nature's Bounty, CRN And Benev

Mary Engle led FTC enforcement actions including against POM Wonderful’s claims for its pomegranate supplements; Huber is CRN’s scientific and regulatory affairs VP and Amanda Darlington is government relations director; Jones takes charge of Nature’s Bounty supply chain; and Benev Co. names five aesthetic experts to Medical Advisory Board to advance its “medically developed cosmeceutical line.”

Blueberry Extract Boosts Cancer Treatment Efficacy, Therapeutic Solutions Says

Therapeutic Solutions says animal study data show synergy in use of NanoStilbene, its proprietary formulation of pterostilbene, together with anti-CTLA4 antibody, "the mouse equivalent" of ipilimumab, an immunotherapeutic in the "checkpoint inhibitors" family of drugs. It also notes early results of clinical trial with cancer patients suggesting NanoStilbene efficacy in increased activity of immune system "natural killer" cells and enhanced production of interferon gamma, a protein associated with cancer growth suppression.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts